CD163 and infection: Interestingly, the SARS‐CoV‐2 peptides which exhibited sequence similarity with CCL3 and CCL3L1 (and CD163) were not homologous with HCoVs (Figure 4d and Table 1)—which may increase the likelihood of being involved in immunopathology after infection.